Asterias Biotherapeutics Financials

Asterias Biotherapeutics Stock Summary

Asterias Biotherapeutics competes with Lincoln Electric, Proficient Auto, Timken, Newell Brands, and Eastman Kodak. Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California. Asterias Biotherapeutics operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 31 people.

Asterias Biotherapeutics Key Financial Ratios

Asterias Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Asterias Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Asterias Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Asterias Biotherapeutics competition to find correlations between indicators driving Asterias Biotherapeutics's intrinsic value. More Info.Asterias Biotherapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Asterias Biotherapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

If you are still planning to invest in Asterias Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asterias Biotherapeutics' history and understand the potential risks before investing.